phrykt

Alignment Healthcare, Inc. (ALHC): who owns it and who trades it

As of Nov 16, 2026, ALHC insiders reported 77 open-market sales worth $311M and 1 purchase worth $198K in the last 12 months, with 25% of the sale value made under pre-set 10b5-1 plans. The largest seller was General Atlantic (ALN HLTH), L.P. (10% owner), with $206M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Alignment Healthcare

From the latest filings

Overall: more selling than buying. Funds and insiders mostly sold. Famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ALHC

2 funds and institutions reported ALHC shares worth $20.4B at the end of Q2 2026, about 6% of the company. The largest holder is Picton Mahoney Asset Management with 5.8%.

Funds and institutions (13F) 6%Everyone else 94%

10 largest owners, by share of the company

Picton Mahoney Asset Management5.8%
Boussard & Gavaudan Gestion Sas0.0%

Top 2 owners

OwnerShares% of companyValueChange since Q1 2026
Picton Mahoney Asset Management12.00M5.80%$20.4B+140%
Boussard & Gavaudan Gestion Sas5,0000.00%$8.6MNew

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ALHC insiders reported $198K of open-market purchases and $311M of sales. 25% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$198K
1 trades, 1 people
Sales, 12 months
$311M
77 trades, 10 people
Sales under a 10b5-1 plan
25%
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 12, 2026

Purchases and sales by month

$232M$232MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Joseph S KonowieckiVice presidentSale4,930$7.20$35.5KForm 4
Oct 6, 2026Hyong KimChief Medical OfficerSale32,479$8.30$270KForm 4
Sep 17, 2026Joseph S KonowieckiVice presidentSale23,511$8.61$202KForm 4
Sep 14, 2026John E KaoCEOSale plan27,400$13.00$356KForm 4
Sep 11, 2026Dawn Christine MaroneyPresidentSale122,707$12.68$1.6MForm 4
Sep 11, 2026John E KaoCEOSale plan385,270$12.68$4.9MForm 4
Sep 10, 2026John E KaoCEOSale plan172,600$12.96$2.2MForm 4
Aug 14, 2026Dawn Christine MaroneyPresidentSale plan5,000$14.00$70KForm 4
Aug 10, 2026John E KaoCEOSale plan298,000$13.88$4.1MForm 4
Jul 15, 2026Dawn Christine MaroneyPresidentSale plan177,068$20.83$3.7MForm 4
Jul 10, 2026John E KaoCEOSale plan279,644$19.81$5.5MForm 4
Jul 10, 2026John E KaoCEOSale plan18,356$20.65$379KForm 4
Jul 1, 2026Joseph S KonowieckiVice presidentSale plan25,000$24.00$600KForm 4
Jun 26, 2026Joseph S KonowieckiVice presidentSale plan25,000$23.00$575KForm 4
Jun 18, 2026Joseph S KonowieckiVice presidentSale plan25,000$22.00$550KForm 4
Jun 15, 2026Dawn Christine MaroneyPresidentSale plan30,000$19.55$586KForm 4
Jun 12, 2026Hyong KimChief Medical OfficerSale plan35,951$19.86$714KForm 4
Jun 11, 2026Joseph S KonowieckiVice presidentSale plan25,000$21.00$525KForm 4
Jun 10, 2026John E KaoCEOSale plan74,936$19.65$1.5MForm 4
Jun 10, 2026John E KaoCEOSale plan223,064$20.60$4.6MForm 4
Jun 2, 2026Mark D. KentPresidentPurchase14,848$13.31$198KForm 4
May 15, 2026Dawn Christine MaroneyPresidentSale plan30,000$16.09$483KForm 4
May 11, 2026John E KaoCEOSale plan280,893$16.85$4.7MForm 4
May 11, 2026John E KaoCEOSale plan17,107$17.54$300KForm 4
Apr 15, 2026Dawn Christine MaroneyPresidentSale plan30,000$20.87$626KForm 4
Apr 13, 2026John E KaoCEOSale plan82,299$20.80$1.7MForm 4
Apr 10, 2026John E KaoCEOSale plan201,900$20.58$4.2MForm 4
Apr 10, 2026John E KaoCEOSale plan13,801$21.38$295KForm 4
Apr 7, 2026James M HeadCFOSale11,100$21.08$234KForm 4
Apr 7, 2026John E KaoCEOSale plan117,759$21.40$2.5MForm 4
Apr 7, 2026John E KaoCEOSale plan132,241$20.67$2.7MForm 4
Apr 1, 2026Christopher J JoyceChief Legal and Admin. OSale plan18,013$17.79$320KForm 4
Mar 23, 2026John E KaoCEOSale plan118,000$17.48$2.1MForm 4
Mar 19, 2026Andreas P. WagnerChief Human Resources OfSale plan11,602$18.22$211KForm 4
Mar 18, 2026Sebastian BurzacchiCOO - Mgmt Services OrgSale15,361$17.84$274KForm 4
Mar 18, 2026Hyong KimChief Medical OfficerSale18,404$17.84$328KForm 4
Mar 18, 2026Christopher J JoyceChief Legal and Admin. OSale25,125$17.84$448KForm 4
Mar 18, 2026Dawn Christine MaroneyPresidentSale36,749$17.84$656KForm 4
Mar 18, 2026John E KaoCEOSale73,046$17.84$1.3MForm 4
Mar 18, 2026Robert L. ScavoChief Information OfficeSale11,285$17.84$201KForm 4
Mar 18, 2026Andreas P. WagnerChief Human Resources OfSale plan12,000$17.84$214KForm 4
Mar 16, 2026Dawn Christine MaroneyPresidentSale plan30,000$17.48$524KForm 4
Mar 12, 2026Robert L. ScavoChief Information OfficeSale3,799$17.48$66.4KForm 4
Mar 12, 2026Robert L. ScavoChief Information OfficeSale245$16.99$4.2KForm 4
Mar 12, 2026Dawn Christine MaroneyPresidentSale1,763$16.99$30KForm 4
Mar 12, 2026Dawn Christine MaroneyPresidentSale27,350$17.48$478KForm 4
Mar 12, 2026John E KaoCEOSale45,938$17.48$803KForm 4
Mar 12, 2026John E KaoCEOSale2,961$16.99$50.3KForm 4
Mar 10, 2026John E KaoCEOSale plan180,000$18.19$3.3MForm 4
Mar 4, 2026Andreas P. WagnerChief Human Resources OfSale plan21,118$18.62$393KForm 4
Feb 17, 2026Dawn Christine MaroneyPresidentSale plan30,000$20.63$619KForm 4
Feb 10, 2026Andreas P. WagnerChief Human Resources OfSale22,238$20.47$455KForm 4
Feb 10, 2026John E KaoCEOSale plan180,000$20.49$3.7MForm 4
Jan 15, 2026Dawn Christine MaroneyPresidentSale plan14,871$22.78$339KForm 4
Jan 15, 2026Dawn Christine MaroneyPresidentSale plan15,129$22.19$336KForm 4
Jan 12, 2026John E KaoCEOSale plan177,273$21.10$3.7MForm 4
Jan 12, 2026John E KaoCEOSale plan2,727$21.57$58.8KForm 4
Jan 6, 2026Hyong KimChief Medical OfficerSale plan16,506$21.35$352KForm 4
Jan 6, 2026Dawn Christine MaroneyPresidentSale plan228,152$21.33$4.9MForm 4
Jan 2, 2026Christopher J JoyceChief Legal and Admin. OSale plan10,611$20.03$213KForm 4
Jan 2, 2026Dawn Christine MaroneyPresidentSale plan100,000$20.03$2MForm 4
Dec 29, 2025Robert L. ScavoChief Information OfficeSale3,813$19.38$73.9KForm 4
Dec 29, 2025Robert L. ScavoChief Information OfficeSale65,728$18.71$1.2MForm 4
Dec 29, 2025Hyong KimChief Medical OfficerSale696$19.38$13.5KForm 4
Dec 29, 2025Hyong KimChief Medical OfficerSale11,998$18.71$224KForm 4
Dec 29, 2025John E KaoCEOSale33,211$19.38$644KForm 4
Dec 29, 2025John E KaoCEOSale572,437$18.71$10.7MForm 4
Dec 29, 2025Dawn Christine MaroneyPresidentSale266,603$18.71$5MForm 4
Dec 29, 2025Dawn Christine MaroneyPresidentSale15,467$19.38$300KForm 4
Dec 29, 2025Christopher J JoyceChief Legal and Admin. OSale15,299$18.71$286KForm 4
Dec 29, 2025Christopher J JoyceChief Legal and Admin. OSale888$19.38$17.2KForm 4
Dec 15, 2025Dawn Christine MaroneyPresidentSale plan113,319$20.01$2.3MForm 4
Dec 12, 2025Dawn Christine MaroneyPresidentSale plan16,681$20.02$334KForm 4
Dec 12, 2025General Atlantic (ALN HLTH), L.P.10% ownerSale11.12M$18.57$206MForm 4
Dec 10, 2025Sebastian BurzacchiCOO - Mgmt Services OrgSale12,585$19.26$242KForm 4
Dec 10, 2025John E KaoCEOSale plan180,000$19.02$3.4MForm 4
Dec 8, 2025Christopher J JoyceChief Legal and Admin. OSale plan19,706$19.33$381KForm 4
Nov 25, 2025Joseph S KonowieckiDirectorSale plan25,000$19.00$475KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
General Atlantic (ALN HLTH), L.P.10% owner–$206MDec 12, 2025
John E KaoChief Executive Officer, Director–$69.8MSep 14, 2026
Dawn Christine MaroneyPresident–$24.7MSep 11, 2026
Joseph S KonowieckiDirector–$3MNov 10, 2026
Hyong KimChief Medical Officer–$1.9MOct 6, 2026
Christopher J JoyceChief Legal and Admin. Officer–$1.7MApr 1, 2026
Robert L. ScavoChief Information Officer–$1.6MMar 18, 2026
Andreas P. WagnerChief Human Resources Officer–$1.3MMar 19, 2026
Sebastian BurzacchiCOO - Mgmt Services Org–$516KMar 18, 2026
James M HeadChief Financial Officer–$234KApr 7, 2026
Mark D. KentPresident - MSO$198K–Jun 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ALHC short interest

High short interest. 11.1% of ALHC shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went down 8%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 23.15M ALHC shares were sold short, 11.1% of the shares outstanding, down 9.3% from the report before. At the average daily volume of 5.93M shares, buying them all back would take about 3.9 trading days (days to cover).

Shares short, % of all shares

11.1%May 15Oct 3012.6%

Days to cover

3.9May 15Oct 308.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202623.15M11.06%-9%5.93M3.9
Oct 15, 202625.52M12.30%+8%11.33M2.2
Sep 30, 202623.61M11.38%-4%14.64M1.6
Sep 15, 202624.62M11.87%+8%6.96M3.5
Aug 31, 202622.84M11.01%-3%3.78M6.0
Aug 14, 202623.53M11.35%+7%6.54M3.6
Jul 31, 202622.05M10.63%-11%4.78M4.6
Jul 15, 202624.81M12.00%+2%5.32M4.7
Jun 30, 202624.37M11.79%-4%5.14M4.7
Jun 15, 202625.42M12.30%-0%8.13M3.1
May 29, 202625.44M12.30%+1%3.46M7.4
May 15, 202625.08M12.13%+56%9.24M2.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Alignment Healthcare company events

Alignment Healthcare filed 9 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Oct 8, 2026AnnouncementShared information with investors. Filing
  3. Jul 30, 2026ResultsReleased financial results. Filing
  4. Jun 9, 2026VoteReported shareholder vote results. Filing
  5. May 12, 2026RulesChanged its bylaws or articles. Filing
  6. Apr 30, 2026ResultsReleased financial results. Filing
  7. Mar 4, 2026AgreementAlignment Healthcare, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto with respect to an underwritten offering by the Selling Stockholder of 13,167,733 shares of the Company’s common stock, par value $0.001 per… Filing
  8. Feb 26, 2026ResultsReleased financial results. Filing
  9. Jan 12, 2026AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Alignment Healthcare financials

Famous investors that hold ALHC

5 of the 50 well-known investors we track reported holding ALHC in their latest 13F filing. The largest position is Israel Englander's, worth $36.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20264.48M$36.5M0.0%+206%
Ken Griffin · Citadel AdvisorsQ3 20263.14M$25.6M0.0%New
Steve Cohen · Point72 Asset ManagementQ3 20261.99M$16.2M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 2026822,529$6.7M0.0%New
Jim Simons · Renaissance TechnologiesQ3 2026667,900$5.5M0.0%-33%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named ALHC in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Invesco Ltd.13G/A1.6%
Nov 10, 2026Invesco Ltd.13G/A1.6%
Nov 5, 2026FMR LLC13G/A4.3%
Nov 5, 2026FMR LLC13G/A4.3%
Oct 5, 2026BlackRock, Inc.13G/A11.3%
Oct 5, 2026BlackRock, Inc.13G/A11.3%

Questions about Alignment Healthcare, Inc. (ALHC) stock

Who owns the most ALHC stock?

The largest reported owner of Alignment Healthcare, Inc. (ALHC) is Picton Mahoney Asset Management, with 5.8% of the company. In total, 2 funds and institutions reported holding ALHC at the end of Q2 2026, together about 6% of the shares. See the largest owners.

Are ALHC insiders buying or selling?

In the last 12 months, ALHC insiders reported 1 open-market purchase worth $198K and 77 sales worth $311M. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in ALHC?

As of Oct 30, 2026, 23.15M ALHC shares were sold short, 11.1% of the shares outstanding, down 9.3% from the report before. At the average daily volume of 5.93M shares, buying them all back would take about 3.9 trading days (days to cover). See the history.

Which famous investors hold ALHC?

5 of the 50 well-known investors we track reported ALHC in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $36.5M. See all holders.

Executive pay

Alignment Healthcare's chief executive was paid a total of $11.3M for the year ended Dec 31, 2025, up 77% from $6.4M the year before. In the last 12 months, Alignment Healthcare's executives and directors bought $198K of stock on the open market and sold $105M.

Chief executive, total pay$11.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$52.3MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$3.6MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.